Filter posts

Research: Working Together Toward Cures

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require …

What Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?

The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more …

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the …

Five Keys to Making Biotech Flourish in China

As China positions itself as a major global player in the international biotechnology arena, it …

Value Drivers Under the Influence – How Licensing and Key Events Affect Valuation

The Tuesday plenary luncheon at the 2012 BIO CEO & Investor Conference featured a panel …

Fireside Chat with Dr. Mikael Dolsten

Day two of the BIO CEO & Investor Conference kicked off with a Fireside Chat …

“Alz” Well That Ends Well: The Beta-Amyloid Debate in Alzheimer’s Research

Researchers and clinicians alike believe there is substantial evidence to support the hypothesis that Alzheimer’s …

Maryland Awards $1 Million to Five Biotech Small Businesses

In effort to spur commercialization and advance treatments for cancer and other diseases, the Maryland …

Biomedical Innovation: How the U.S. Can Stay Number One

By Ross DeVol, chief research officer of the Milken Institute “The first step in winning …

The Ethics of Global Clinical Trials

By Dr. Russell Medford, Salutria Pharmaceuticals Recent reports have raised concerns about how clinical trials are …